The US Food and Drug Administration told a nationally licensed pharmacist on WednesdayPfizerInc PFE.N COVID -19pill,Paxlovid, to eligible patients.
The use of pills allowed to treat people at new risk of infection to prevent serious illness has skyrocketed in recent weeks as infections have increased. doing.
"Because you need to take Paxrovid within 5 days of the onset of symptoms, allowing a nationally licensed pharmacist to prescribe Paxrovid will help some patients be treated in a timely manner. Access may increase, "drug assessments and studies said in a statement.
Authorities said patients who tested positive for COVID-19 should bring their health records for confirmation by pharmacists. Kidney and liver problems.
Trend Story
Story follows below the ad
Agency is a pharmacist Patients of medical professionals who are allowed to prescribe drugs if there is not enough information to assess kidney or liver function, or if changes are needed due to potential drug interactions .
Patients should also provide a list of medications they are currently taking . This allows pharmacists to screen for drugs that may react with the FDA Paxlovid. said.
(Report by Manas Mishra in Bangalore, edited by Shinjini Ganguli)
© 2022 Reuters